Cielo Health GLP-1

Description

Medical and editorial disclaimer: This article is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Cielo Health offers access to prescription compounded medications subject to medical evaluation and provider approval. Compounded medications are not FDA-approved, and the FDA does not review them for safety, effectiveness, or quality before they are marketed. Eligibility, prescribing decisions, dosage, potential benefits, risks, and treatment duration must be determined by a qualified healthcare professional. Prices, availability, pharmacy arrangements, and program terms may change.

Introduction

Cielo Health is an online weight-management platform that promotes physician-led access to compounded semaglutide and compounded tirzepatide. Its service is designed for adults who want to explore GLP-1-based medical weight-management care without relying exclusively on traditional in-person appointments.

The company presents its approach as a “gentler way forward,” emphasizing accessible medical intake, transparent pricing, medication delivery, ongoing provider support, and treatment adjustments over time. According to Cielo’s website, the process begins with a secure online medical assessment reviewed by a licensed physician. If the provider determines that treatment is appropriate, a prescription may be issued and medication shipped to the patient’s home.

Cielo currently advertises two principal treatment options:

• Compounded semaglutide starting at $115 per month
• Compounded tirzepatide starting at $180 per month

The advertised starting prices are connected to three-month plans and are presented as applying across dose levels. These figures should be understood as promotional starting prices rather than guaranteed final costs for every patient.

The platform may appeal to people looking for a remote, structured weight-management service that combines medication access with clinical oversight. However, prospective patients must understand an important distinction: the compounded medications offered through programs such as Cielo are not the same regulatory products as FDA-approved branded semaglutide or tirzepatide medications.

Compounded drugs are not FDA-approved. The FDA does not evaluate a compounded medication’s safety, effectiveness, or manufacturing quality before it reaches the market in the same way it evaluates an approved drug. Compounding may serve a legitimate medical need in certain circumstances, but it also introduces considerations involving formulation, dosing, labeling, sterility, pharmacy oversight, and legal availability.

This review explains how Cielo Health works, what its plans reportedly include, how semaglutide and tirzepatide function, what the program costs, and what prospective patients should verify before enrolling.

What Is Cielo Health?

Cielo Health is a telehealth service focused primarily on prescription weight-management treatment. Rather than requiring an initial visit to a physical clinic, Cielo uses an online intake process through which prospective patients provide medical and health information for review.

The company describes its care model as fully online and physician-led. Its website emphasizes four primary components:

1. A secure online medical intake
2. Review by a licensed physician
3. Prescription medication delivery for eligible patients
4. Continuing support and treatment follow-up

Cielo’s stated objective is not simply to mail medication. The company positions itself as an ongoing care service in which treatment may be adjusted as the patient’s needs and response change. Its website says that personalized dosing, physician review, provider access, refill assistance, and follow-up support are included in the care experience.

However, access is not automatic. Semaglutide and tirzepatide are prescription medications. Completing an online form does not guarantee that a prescription will be issued. A licensed healthcare provider must evaluate whether treatment is medically appropriate based on the patient’s health history, current medications, potential contraindications, weight-management needs, and other relevant factors.

The provider—not Cielo’s marketing department—makes the prescribing decision.

How the Cielo Health Process Works

Cielo presents its enrollment process as a relatively straightforward path from medical intake to ongoing care.

Step 1: Complete the Online Medical Intake

A prospective patient begins by completing a secure health questionnaire. The intake may request information such as:

• Age
• Height and weight
• Weight-management history
• Existing health conditions
• Current prescription medications
• Allergies
• Previous experience with GLP-1 medication
• Pregnancy or breastfeeding status
• History of gastrointestinal, endocrine, kidney, gallbladder, or pancreatic concerns
• Personal or family medical history

Patients should answer every question accurately. Omitting medical conditions, medications, allergies, or previous adverse reactions could interfere with the provider’s ability to make an informed prescribing decision.

Telehealth does not reduce the importance of a thorough medical history. It simply changes how the information is collected and reviewed.

Step 2: Licensed-Provider Review

Cielo states that its online intake is reviewed by licensed physicians. The reviewing provider determines whether the applicant appears to be an appropriate candidate for treatment.

The provider may approve treatment, request further information, recommend another option, or decline to prescribe. Depending on the patient and applicable state requirements, additional communication, laboratory testing, medical documentation, or follow-up may be needed.

Patients should confirm:

• The name and credentials of the prescribing provider
• The state in which the provider is licensed
• How medical questions are handled
• Whether live consultations are available
• How urgent concerns are escalated
• Whether lab work is required
• How prescriptions and refills are authorized

Step 3: Treatment Selection

Cielo advertises compounded semaglutide and compounded tirzepatide. Treatment selection should be based on the provider’s medical judgment rather than price, promotional claims, or the patient’s preference alone.

Semaglutide and tirzepatide do not work in exactly the same way. They may also differ in dosing, tolerability, contraindications, expected response, availability, and cost.

A responsible provider should explain why a particular treatment is being recommended and what alternatives may be available.

Step 4: Prescription and Pharmacy Fulfillment

When a patient is approved, the prescription is sent for fulfillment. Cielo states that it works with pharmacy partners and arranges discreet home delivery. The company also says that physician consultation and shipping are included in its advertised program pricing.

The exact pharmacy may vary depending on location, availability, formulation, and program arrangements. Before using the medication, patients should examine the prescription label and confirm:

• The dispensing pharmacy’s full name
• Pharmacy contact information
• The prescribed concentration
• The dose in milligrams
• The corresponding injection volume
• Storage requirements
• Beyond-use date
• Instructions for missed doses
• Whether the vial contains any additional ingredient
• Whether the medication is compounded under a patient-specific prescription

Patients should contact the prescribing provider or dispensing pharmacist when any instruction is unclear.

Step 5: Medication Delivery

Cielo promotes quick, discreet home delivery and says medication may arrive within a few days. Delivery timing should nevertheless be viewed as an estimate rather than a guarantee. Processing may depend on provider approval, prescription transmission, pharmacy workload, state rules, weekends, holidays, inventory, payment, and shipping conditions.

Because injectable medications may have specific temperature and storage requirements, patients should follow the pharmacy’s instructions immediately after delivery.

A package that is damaged, leaking, unusually warm, incorrectly labeled, or delivered outside the expected timeframe should be discussed with the pharmacy before the medication is used.

Step 6: Ongoing Follow-Up

Cielo says its plans include continuing access to providers, refill help, follow-up care, and treatment support. The company describes its care plans as adaptable over time rather than fixed from the beginning.

Follow-up is important because GLP-1-related treatment may involve:

• Gradual dose increases
• Monitoring of gastrointestinal effects
• Review of eating patterns and hydration
• Changes in appetite or food tolerance
• Evaluation of weight trends
• Medication interactions
• Decisions about maintaining, increasing, reducing, or stopping a dose
• Consideration of laboratory testing
• Monitoring for warning signs requiring medical attention

Patients should know how often routine follow-ups occur and whether provider contact is proactive or initiated only when the patient requests help.

What Is Compounded Semaglutide?

Semaglutide is a GLP-1 receptor agonist. GLP-1 is a naturally occurring hormone involved in appetite, digestion, insulin signaling, and blood-glucose regulation.

Semaglutide activates GLP-1 receptors and may influence several processes relevant to weight management, including appetite signaling and the rate at which food leaves the stomach. These effects can help some patients feel satisfied with less food and maintain a reduced calorie intake.

Cielo describes its compounded semaglutide program as a prescription option that may support appetite regulation and weight management when prescribed by a licensed provider. The company advertises personalized dosing and clinical oversight as part of the program.

The word compounded is essential. A compounded semaglutide product is prepared by a compounding pharmacy for use under applicable compounding laws. It is not automatically interchangeable with an FDA-approved semaglutide product, and it should not be called a generic version of an FDA-approved brand.

The FDA has specifically warned companies not to describe non-FDA-approved compounded GLP-1 products as generic versions or as being the same as FDA-approved medications.

Patients should therefore avoid assuming that every semaglutide product has the same formulation, concentration, delivery device, dosing instructions, evidence base, or regulatory status.

What Is Compounded Tirzepatide?

Tirzepatide acts through both glucose-dependent insulinotropic polypeptide, commonly called GIP, and GLP-1 receptor pathways. This dual activity distinguishes it from medications that act only as GLP-1 receptor agonists.

Its actions may affect appetite, food intake, digestion, insulin signaling, and metabolic regulation. As with semaglutide, individual response varies, and use requires medical supervision.

Cielo markets compounded tirzepatide as its higher-priced weight-management option. The company advertises it starting at $180 per month with a three-month plan.

The same regulatory distinction applies: compounded tirzepatide is not an FDA-approved drug. It should not be represented as identical to an approved branded tirzepatide medication, even when it contains the same named active ingredient.

Patients should ask the prescriber and pharmacy why a compounded version is being recommended, whether an FDA-approved treatment is available and appropriate, and what patient-specific need supports the compounded prescription.

Compounded Medication Versus FDA-Approved Medication

This is the most important section for anyone evaluating Cielo Health.

FDA-approved drugs undergo agency review before approval. That review evaluates evidence relating to safety, effectiveness, labeling, dosage forms, manufacturing controls, and product quality.

Compounded medications do not undergo that premarket approval process. According to the FDA, compounded drugs are not FDA-approved, meaning the agency does not verify their safety, effectiveness, or quality before they are marketed.

This does not mean every compounded medication is inherently inappropriate. Compounding can serve patients who have a legitimate clinical need that cannot be met by a commercially available approved drug. Examples in general compounding practice may include a need for a different dosage form, the removal of a particular inactive ingredient, or a patient-specific dose that is not commercially offered.

Nevertheless, prospective patients should understand the additional questions that compounded treatment creates:

• Which pharmacy prepares the medication?
• Is that pharmacy licensed in the patient’s state?
• Is it a traditional 503A compounding pharmacy or a 503B outsourcing facility?
• What exactly is in the formulation?
• What concentration is supplied?
• Is the prescription patient-specific?
• How is potency assessed?
• How is sterility evaluated?
• What testing does the pharmacy perform?
• How are adverse events handled?
• What happens if the product is recalled?
• Why is a compounded drug clinically appropriate for this patient?

Cielo’s website states that it works with regulated pharmacy partners and that batches are tested. Those are company representations. Patients should request specific information about the dispensing pharmacy and the type of testing performed rather than assuming that “tested” means FDA-approved or independently certified to a particular standard.

The Changing Regulatory Environment for Compounded GLP-1 Drugs

The legal and regulatory environment for compounded semaglutide and tirzepatide has changed significantly.

Compounding expanded during periods when FDA-approved GLP-1 medications appeared on the FDA’s drug-shortage list. However, the FDA subsequently determined that the national shortages of tirzepatide injection and semaglutide injection products had been resolved.

The resolution of a shortage affects when compounders may lawfully produce products that are essentially copies of commercially available drugs. The exact rules vary depending on the type of compounding facility, patient-specific circumstances, enforcement policies, and other legal factors.

In 2026, the FDA also proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list after stating that it had not identified a clinical need for outsourcing facilities to compound them from bulk substances under that pathway. At the time of the proposal, the agency was accepting public comments before making a final determination.

This environment makes it especially important for patients to ask why a compounded medication is being prescribed and under what legal basis it is being prepared.

A telehealth company should be able to identify the pharmacy fulfilling the prescription and explain the patient-specific nature of the treatment. Statements such as “available to everyone,” “identical to the brand,” or “generic GLP-1” should be treated cautiously.

Cielo Health Pricing

Cielo advertises the following starting prices:

Compounded Semaglutide

• From $115 per month
• Advertised in connection with a three-month plan
• Promotional regular price shown as $199 per month
• All dose levels described as included under the offer

Compounded Tirzepatide

• From $180 per month
• Advertised in connection with a three-month plan
• Promotional regular price shown as $299 per month
• All dose levels described as included under the offer

The company states that physician consultation and shipping are included.

Based on the starting rates, a three-month semaglutide plan would begin at approximately $345, while a three-month tirzepatide plan would begin at approximately $540. These calculations do not account for taxes, optional services, laboratory costs, cancellation rules, renewal pricing, or other possible charges.

Patients should review the final checkout terms before paying.

Questions to ask include:

• Is the entire three-month amount charged upfront?
• Is the subscription billed monthly?
• Does the plan renew automatically?
• Does renewal occur at the promotional price or regular price?
• Are provider consultations truly unlimited?
• Are lab tests included?
• Are needles and injection supplies included?
• Is overnight or expedited shipping included?
• Are there fees for replacement shipments?
• What happens if the provider decides treatment is inappropriate?
• Is any portion refundable after medical review?
• Can the patient cancel during the three-month commitment?
• What happens to an already-issued prescription after cancellation?

The phrase “from $115” or “from $180” indicates a minimum advertised cost. It does not establish what every patient will ultimately pay.

Does Cielo Health Accept Insurance?

The supplied Cielo website text includes “Do you accept insurance?” as a frequently asked question, but the answer is not visible in the provided material. Patients should not assume that the program bills insurance unless Cielo explicitly confirms it during enrollment.

Many online compounded-medication programs operate as cash-pay services. Even when the telehealth subscription itself is not covered, patients may be able to use a health savings account or flexible spending account if the expense qualifies under their plan. Eligibility should be confirmed with the account administrator or a tax professional.

Patients should also compare the total cash cost of Cielo with:

• An FDA-approved medication covered by insurance
• Manufacturer savings programs, where eligible
• A local obesity-medicine specialist
• A primary-care prescription
• A registered dietitian-supported program
• Other telehealth services
• Non-medication weight-management options

The lowest advertised monthly price is not always the lowest overall cost once commitment periods, laboratory testing, supplies, follow-up, and long-term treatment are considered.

What Does Cielo Say Is Included?

Cielo’s website promotes a package that reportedly includes:

• Online medical intake
• Licensed physician review
• Personalized dosing
• Medication delivery
• Shipping
• Physician consultation
• Provider access
• Ongoing follow-up care
• Refill assistance
• Treatment support
• Pharmacy fulfillment
• Batch testing

These features suggest that Cielo is designed as a subscription-style care program rather than a one-time medication purchase.

The exact meaning of each item should still be verified.

For example, “unlimited provider access” may mean messaging through a patient portal rather than unlimited live appointments. “Free consultation” may refer only to the initial review. “Personalized dosing” may mean choosing among standardized titration steps rather than creating a completely unique formulation.

Similarly, “every batch tested” does not explain:

• Who conducts the testing
• Which laboratory is used
• Whether the laboratory is independent
• What specifications are measured
• Whether every dispensed vial is tested
• Whether testing covers sterility, endotoxins, identity, potency, and stability
• Whether certificates of analysis are available

These questions do not prove that anything is wrong. They simply help patients distinguish general marketing language from operational detail.

Potential Benefits of the Cielo Model

Convenient Access

The online intake process may make medical weight-management care easier to access for people who live far from a specialist, have limited appointment availability, or prefer remote communication.

Home Delivery

Shipping medication to the patient may reduce pharmacy visits and simplify monthly treatment logistics.

Structured Follow-Up

A program that includes provider communication and dose review may offer more support than obtaining medication without an organized follow-up system.

Transparent Starting Prices

Cielo displays starting monthly prices on its website. This is useful for preliminary comparison, although final costs and renewal terms still need to be confirmed.

Two Medication Pathways

Offering both compounded semaglutide and compounded tirzepatide gives prescribers more than one potential medication pathway, subject to individual medical appropriateness.

Bilingual Website Access

Cielo’s website includes English and Spanish language options, which may improve accessibility for some patients.

Charitable Positioning

The company states that 10% of its proceeds support charitable organizations. Prospective customers interested in this aspect may wish to ask which organizations receive funds, whether the percentage refers to gross or net proceeds, and whether reports or donation records are available.

Limitations and Concerns to Consider

Compounded Products Are Not FDA-Approved

This is the central limitation. The FDA does not review compounded medications for safety, effectiveness, or quality before marketing.

Pharmacy Information Is Critical

The available homepage language does not identify all pharmacy details needed for a complete independent assessment. Patients should obtain the dispensing pharmacy’s identity before using the medication.

Outcome Percentages Require Context

Cielo’s website reportedly uses claims such as “lose up to 21%” for semaglutide and “lose up to 27%” for tirzepatide.

These percentages must not be interpreted as a promise that a Cielo patient will achieve those outcomes. Results from clinical trials of FDA-approved products cannot automatically be transferred to a compounded product, a different formulation, a different care model, or an individual patient.

The word “up to” generally highlights an upper-end result rather than the typical result. Meaningful interpretation would require information about:

• The study being referenced
• The exact product used
• Dose and treatment duration
• Patient population
• Lifestyle intervention
• Completion rates
• Average versus maximum results
• Adverse-event discontinuations
• Whether the data involved the compounded formulation sold through Cielo

Unless that evidence is provided, the percentages should remain attributed marketing claims rather than independently established outcomes for the Cielo program.

Long-Term Cost

GLP-1-related weight treatment may continue for an extended period. A seemingly manageable monthly price can become a significant annual expense.

At the advertised starting rates:

• Semaglutide would total approximately $1,380 over 12 months
• Tirzepatide would total approximately $2,160 over 12 months

These simple calculations assume the promotional monthly rate remains unchanged and exclude any other costs. Actual annual spending may differ.

Treatment May Not Be Appropriate for Everyone

Medical history, current medications, pregnancy plans, previous reactions, and other health factors can affect eligibility. A provider must evaluate these matters individually.

Side Effects Can Occur

GLP-1 and related therapies commonly involve gastrointestinal side effects. Some complications may be serious and require prompt medical assessment.

Dosing Errors Are Possible

The FDA has received reports of dosing errors involving compounded injectable semaglutide. Confusion may arise when patients must convert a prescribed milligram dose into units or volume drawn from a multidose vial.

Patients should never guess how much medication to inject.

Possible Side Effects and Safety Considerations

The safety profile depends on the medication, dose, formulation, patient, and other health factors. Commonly discussed effects associated with this drug category may include:

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Abdominal discomfort
• Reduced appetite
• Indigestion
• Fatigue
• Headache
• Injection-site reactions

Symptoms may be more noticeable when treatment begins or when the dose is increased.

Patients should receive clear instructions about when to contact the provider and when to seek urgent care. Warning signs can include severe or persistent abdominal pain, repeated vomiting, inability to keep fluids down, signs of dehydration, symptoms of a serious allergic reaction, or other severe or rapidly worsening symptoms.

People with a history involving pancreatitis, gallbladder disease, significant gastrointestinal problems, kidney concerns, certain endocrine tumors, or other relevant conditions should discuss those issues directly with the prescriber.

Pregnant patients, people trying to become pregnant, and those who are breastfeeding should disclose that status during the medical review.

This section is not a complete safety guide. The patient should rely on the prescribing information, pharmacy label, provider instructions, and pharmacist counseling supplied with the actual medication.

The Importance of Correct Dosing

Compounded injectable medications may arrive in multidose vials. Unlike a fixed-dose pen, a vial may require the patient to draw a specific volume into a syringe.

This creates several numbers that must not be confused:

• Milligrams of active medication
• Milligrams per milliliter
• Milliliters to inject
• Syringe units
• Total medication in the vial

For example, a direction to inject a certain number of “units” is incomplete unless the concentration and syringe type are known.

The FDA has warned about compounded semaglutide dosing errors in which patients administered substantially more medication than intended. Some errors involved confusion between milligrams, milliliters, and syringe units.

Before the first injection, a patient should be able to answer:

• What is my prescribed dose in milligrams?
• What is the vial concentration?
• How many milliliters does that equal?
• Where does that amount appear on my syringe?
• How often should I inject?
• What should I do if I miss a dose?
• What should I do if I accidentally inject too much?
• How long can the vial be used after it is first punctured?

A patient who cannot confidently answer these questions should contact the pharmacy or prescriber before injecting anything.

Supporting Muscle During Weight Loss

Cielo states that its care plans are designed to support progress while helping preserve muscle mass.

The wording should be interpreted as a care objective, not a guarantee. Weight loss can include reductions in both fat mass and lean mass. Medication by itself does not ensure that muscle will be preserved.

A clinician-supervised plan may address:

• Appropriate protein intake
• Resistance training
• Overall calorie intake
• Rate of weight loss
• Sleep
• Hydration
• Physical limitations
• Nutrient adequacy
• Existing kidney or metabolic conditions

Nutrition and exercise recommendations must be individualized. A generic high-protein or intensive exercise prescription may not be appropriate for every patient.

Prospective members should ask what Cielo specifically provides in this area. For example:

• Is nutrition counseling included?
• Are registered dietitians available?
• Is resistance-training guidance provided?
• Are body-composition changes monitored?
• Does the provider review protein intake?
• Is there a strategy for patients losing weight too quickly?

Who May Be Interested in Cielo?

Cielo may be worth exploring for adults who:

• Want a fully online weight-management assessment
• Prefer home delivery
• Are comfortable using injectable medication
• Want ongoing telehealth support
• Understand the difference between compounded and FDA-approved drugs
• Are willing to commit to a multi-month program
• Can follow storage and dosing instructions carefully
• Have access to emergency and primary medical care when needed

Interest does not equal medical eligibility. The decision rests with a licensed provider.

Who Should Be Especially Cautious?

Additional caution may be appropriate for people who:

• Are pregnant, breastfeeding, or planning pregnancy
• Have experienced a serious reaction to a similar medication
• Have a complicated gastrointestinal history
• Have a history of pancreatitis or gallbladder problems
• Take insulin or other medications that may affect blood glucose
• Have difficulty interpreting vial and syringe instructions
• Have a history relevant to thyroid tumors or endocrine syndromes
• Have active eating-disorder concerns
• Cannot maintain adequate hydration
• Lack reliable access to follow-up care
• Are seeking rapid weight loss without long-term medical monitoring

This is not an exhaustive list and should not be used to self-determine eligibility.

Questions to Ask Cielo Before Enrolling

Prospective patients should obtain clear answers to the following questions:

1. Who will prescribe my medication?
2. In which state is the provider licensed?
3. Which pharmacy will fill my prescription?
4. Is the pharmacy licensed to ship to my state?
5. Is the pharmacy operating under section 503A or 503B?
6. Why is a compounded medication appropriate for me?
7. Is an FDA-approved alternative available?
8. What is the exact formulation?
9. Does the formulation include any added ingredients?
10. What is the concentration?
11. How are dose instructions communicated?
12. What testing is performed?
13. Can I review available testing documentation?
14. Are consultation and shipping included?
15. Are supplies included?
16. Are laboratory tests included?
17. Is there a three-month commitment?
18. Does the plan automatically renew?
19. What is the post-promotional price?
20. What is the refund policy?
21. What happens if I am medically ineligible?
22. How quickly can I reach a provider?
23. Is urgent support available after hours?
24. What happens if medication arrives damaged or warm?
25. How are adverse events reported?
26. What is the cancellation process?
27. How are refills authorized?
28. What happens if I want to stop treatment?
29. How will weight maintenance be addressed?
30. What lifestyle or nutrition support is included?

A trustworthy provider should answer these questions without pressuring the patient to make an immediate purchase.

Cielo Health Pros and Cons

Potential Advantages

Cielo offers an online enrollment process, advertised transparent starting prices, two medication options, home shipping, physician review, refill support, and ongoing follow-up. The bilingual website may also improve accessibility.

Its starting prices appear lower than the cash cost commonly associated with some FDA-approved branded medications, although a direct comparison must account for insurance, savings programs, formulation differences, clinical appropriateness, and regulatory status.

Potential Disadvantages

The medications are compounded and not FDA-approved. The advertised outcome percentages require substantiation and should not be treated as expected results. Customers must clarify the pharmacy identity, formulation, testing practices, billing structure, cancellation rights, and renewal price.

The legal availability of compounded GLP-1 products has also become more complex following the resolution of national shortages and increased FDA enforcement attention.

Is Cielo Health Legitimate?

The available information shows that Cielo operates a public-facing telehealth website advertising physician-reviewed access to compounded semaglutide and tirzepatide. However, the word “legitimate” can refer to several different questions:

• Is the business legally registered?
• Are its prescribers properly licensed?
• Are its pharmacy partners licensed?
• Are prescriptions issued after valid medical review?
• Are its advertising claims adequately substantiated?
• Are its compounded products prepared within applicable law?
• Are its prices and cancellation terms transparent?
• Is its customer support reliable?
• Does its fulfillment process meet patient expectations?

A website and advertised physician review are not enough to independently answer all of these questions.

Before enrolling, consumers should verify provider licensing through the relevant state medical board and pharmacy licensing through the applicable state board of pharmacy. They should also read the terms of service, privacy policy, subscription agreement, refund terms, and consent forms.

No claim should be made that Cielo is FDA-approved. The FDA approves drugs and certain medical products; it does not generally “approve” telehealth companies. Likewise, a pharmacy’s legal registration does not mean each compounded product has received FDA approval.

Frequently Asked Questions

What is Cielo Health?

Cielo Health is an online healthcare platform that promotes access to compounded semaglutide and compounded tirzepatide for weight management. The process reportedly includes an online medical intake, physician review, home delivery for eligible patients, personalized dosing, and ongoing provider support.

Does Cielo guarantee that I will receive medication?

No. Prescription approval should depend on a licensed provider’s medical evaluation. Completing an intake form or paying for an assessment does not necessarily mean the provider will determine that medication is appropriate.

How much does Cielo cost?

Cielo advertises compounded semaglutide from $115 per month and compounded tirzepatide from $180 per month when purchased through a three-month plan. Pricing, eligibility, billing schedules, and renewal terms should be confirmed before checkout.

Are Cielo medications FDA-approved?

The compounded medications themselves are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before marketing.

Is compounded semaglutide a generic version of an approved brand?

It should not be described that way. The FDA has stated that companies cannot claim non-FDA-approved compounded products are generic versions of, or the same as, FDA-approved drugs.

Does the price include every dosage?

Cielo’s website says its promotional three-month pricing applies to all doses. Patients should verify this in the written payment and subscription terms because promotional conditions may change.

Is shipping included?

Cielo states that shipping is included. Actual delivery timing may vary based on provider approval, pharmacy processing, location, and shipping conditions.

How quickly does medication arrive?

Cielo says medication may arrive within a few days. That is a company estimate rather than a universal guarantee. The prescription must first be approved and processed.

Does Cielo provide ongoing support?

The company advertises unlimited provider access, ongoing follow-up, refill assistance, and support throughout treatment. Prospective patients should clarify which communication channels are available and whether live appointments are included.

Can Cielo guarantee 21% or 27% weight loss?

No individual result can be guaranteed. Cielo’s percentage statements are marketing claims that require context regarding the supporting studies, exact medication, duration, population, and treatment protocol. Results from studies of FDA-approved products should not automatically be attributed to compounded formulations.

Are there risks with compounded GLP-1 medication?

Yes. In addition to medication-related side effects, compounded products may present concerns involving concentration, dosing, sterility, labeling, formulation, and quality. The FDA has warned about dosing errors involving compounded semaglutide.

Can I cancel at any time?

Cielo lists cancellation as an FAQ topic, but the answer was not included in the supplied website text. Because the advertised rates are tied to a three-month plan, patients should read the cancellation and refund terms before paying.

What happens when treatment stops?

Appetite and weight may change after medication is discontinued. The outcome varies by patient. A transition or maintenance strategy should be discussed with the prescriber rather than stopping treatment without guidance.

Does Cielo replace a primary-care doctor?

No. A focused telehealth weight-management service should not replace comprehensive primary care, emergency care, preventive screening, or specialist treatment.

Final Verdict

Cielo Health presents a convenient telehealth model for adults interested in physician-supervised access to compounded semaglutide or compounded tirzepatide.

Its main advertised strengths are straightforward online intake, starting prices displayed publicly, home delivery, physician review, personalized dosing, and continuing support. Semaglutide starts at a reported $115 per month, while tirzepatide starts at a reported $180 per month under three-month promotional plans.

However, the program should not be evaluated on convenience and price alone.

The medications are compounded and are not FDA-approved. Prospective patients should verify the prescribing provider, dispensing pharmacy, formulation, concentration, testing procedures, legal basis for compounding, billing commitment, cancellation policy, renewal rate, and emergency-support process.

Cielo’s advertised weight-loss percentages should remain clearly attributed to the company and should not be interpreted as guaranteed, typical, or independently verified outcomes for patients using Cielo’s compounded formulations.

For an appropriate patient who understands these limitations and receives a genuine individualized medical evaluation, Cielo may offer a convenient path to supervised weight-management care. For someone who assumes compounded medication is identical to an FDA-approved product, expects guaranteed results, or does not receive clear pharmacy and dosing information, the program may not be an appropriate choice.

The best decision is made after comparing Cielo with FDA-approved treatment options, insurance-covered care, local clinicians, and other medically supervised programs—and after discussing the risks and benefits with a qualified healthcare professional.

Affiliate disclosure: This article may contain affiliate links. If a purchase or enrollment is completed through a qualifying link, compensation may be received at no additional cost to the reader.

Compounded-medication disclosure: Compounded semaglutide and compounded tirzepatide are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed. A prescription should be issued only when a licensed provider determines that a compounded medication is appropriate for an individual patient.

Results disclaimer: Weight-management results vary. No specific amount or rate of weight loss is guaranteed. Outcomes depend on individual health, treatment adherence, dose, duration, nutrition, physical activity, tolerability, and other factors.

Pricing disclaimer: Pricing and program terms were based on information displayed by Cielo Health at the time of review and may change. Promotional prices may require a three-month plan and may not include every possible cost.